Press releaseACCESS Newswire
Afinida
TREP · OTC
$0.013−$0.002 (−13.33%)TodayMarket closed ·
Prev close $0.015
Latest news
- Press releaseACCESS Newswire
Afinida Reports $16.9M in Q3 2025 Revenue, Expands Subsidiary Growth
- Press releasePRNewswire
Afinida Marketing Delivers 19.4% Revenue Growth in Q2, Bolstering Parent Company Results
- Press releaseACCESS Newswire
Afinida Revenues Grow 13% - on Pace for Record-Setting Year
- Press releasePRNewswire
Trucept, Inc. Officially Changes Operating Name to Afinida, Inc. for Improved Business Continuity
- Press releaseACCESS Newswire
Afinida CEO Norman Tipton Retires, Search for Replacement Underway
- Press releasePRNewswire
Afinida Reports Increase of Nearly $3.3 Million in Net Revenues for 2024
- Press releaseACCESS Newswire
Afinida Accounting to Offer Fractional CFO Services to Small and Medium-Sized Businesses
- Press releasePRNewswire
Afinida Announces New Marketing Contracts Totaling Nearly Half a Million Dollars in Annual Revenue
- Press releasePRNewswire
Afinida Marketing Doubles in Size to Facilitate Increasing Client Demand
- Press releasePRNewswire
Trucept, Inc. DBA Afinida Reports Strong Q3 2024 Financial Results, Marking Sustained Growth and Profitability
- Press releasePRNewswire
Brendan McMenamy Promoted to Chief Financial Officer at Afinida
- Press releasePRNewswire
Trucept, Inc. Announces Release of 2022 Audited Financials and Upcoming 2023 Report
- Press releasePRNewswire
Trucept, Inc. (DBA Afinida) Reports Substantial Increase in Revenue and Gross Profit for the Second Quarter of 2024
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.